Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Buys Analytica

NEW YORK (GenomeWeb News) – PerkinElmer said on Tuesday that it has purchased the mass spectrometry company Analytica of Branford for an undisclosed sum.

Analytica, based in Branford, Conn., produces electrospray ionization source technology for mass spectrometry.

PerkinElmer said the acquisition is part of its strategic plan to expand its human and environmental health portfolio, and that it will "gain significant insight and intellectual property" in ion source and mass spec technologies.

"The acquisition of Analytica will allow us to offer our customers access to critical technologies such as time-of-flight and quadrupole mass spectrometers and new ion sources that provide more complete information as well as better throughput," Richard Begley, president of PerkinElmer's Analytical Sciences segment, said in a statement.

Under the agreement, PerkinElmer will integrate Analytica's current manufacturing operations into its facility in Shelton, Conn., and it will use the company's Branford facility for research and development projects.

PerkinElmer said it will hire Analytica Founder and President Craig Whitehouse to oversee its mass spec R&D operations.

Financial terms of the agreement were not released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.